Review study reports substantial global mortality burdens and treatment strategies for cystitis in women, highlighting the clinical role of first-line antimicrobial agents.
Bladder inflammation, commonly brought on by a bladder infection, is known as cystitis. This sort of urinary tract infection (UTI) is widespread, especially in women, and is usually not as significant of a problem as it seems. Bacteria in the lower urinary tract are typically the cause of cystic cystitis. The bacteria Escherichia coli is typically the cause, accounting for 95% of cases. Bacteria can occasionally enter the bladder through the urethra and cause cystitis, an inflammation of the bladder typically brought on by a bladder infection. It's a prevalent kind of urinary tract infection (UTI), especially in women, and typically only causes minor discomfort rather than alarm. When treating women with simple acute cystitis, trimethoprim-sulfamethoxazole (TMP-SMX), fosfomycin, or nitrofurantoin monohydrate/macrocrystals are the first-choice medications. When other suggested medications are not effective, beta-lactam antibiotics may be utilized. 33.54% of people had a UTI, with 66.78% female and 33.22% male. In India, there was a higher frequency in females than in males (2:1). 2019 estimates for the world included 404.61 million cases, 236,790 deaths, and 520,200 DALYs. Specifically, there was a 2.4-fold increase in deaths between 1990 and 2019, and the age-standardized mortality rate (ASMR) went from 2.77/100,000 to 3.13/100,000. In this review study, we discuss the causes, prevalence, available treatments, and current status of cystitis.
No takes yet. Share an insight, caveat, or question.
Srivastav et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: